CEACAM-5

CEACAM-5 분자 정보

영어 이름Carcinoembryonic antigen related cell adhesion molecule 5시판 약물 수0
임상 약물 수18표적 별명CEA Cell Adhesion Molecule 5,CEACAM5,Meconium antigen 100,CEA,Carcinoembryonic Antigen Related Cell Adhesion Molecule 5,Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5,Carcinoembryonic Antigen,CD66e Antigen,CD66e
최고 연구 개발 단계Phase 3 Clinical
영어 이름Carcinoembryonic antigen related cell adhesion molecule 5
표적 별명CEA Cell Adhesion Molecule 5,CEACAM5,Meconium antigen 100,CEA,Carcinoembryonic Antigen Related Cell Adhesion Molecule 5,Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5,Carcinoembryonic Antigen,CD66e Antigen,CD66e
시판 약물 수0
임상 약물 수18
최고 연구 개발 단계Phase 3 Clinical

CEACAM-5분자 배경

Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) is also Carcinoembryonic antigen (CEA), Meconium antigen 100, CD antigen CD66e, CEACAM5 belongs to the immunoglobulin superfamily and CEA family. CEACAM5 contains seven Ig-like (immunoglobulin-like) domains. CEACAM5 is homodimer protein which binding of E.coli Dr adhesins leads to dissociation of the homodimer. CEACAM5 is cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. CEACAM5 is receptor for E.coli Dr adhesins.

CEACAM-5분자 별명

CEACAM-5,CD66e,CEA,Meconium antigen 100

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Tusamitamab RavtansineSAR-408701; IBI-126Phase 3 ClinicalImmunogen IncAdenocarcinoma; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Lung Neoplasms; Metastatic breast cancer; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms
상세
SGM-101SGM-101Phase 3 ClinicalSurgimab SasBrain Diseases; Brain metastases; Brain Neoplasms; Colonic Diseases; Colonic Neoplasms; Colorectal Neoplasms; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Diseases; Intestinal Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms
상세
Cancer vaccine (BN ImmunoTherapeutics/National Cancer Institute)CVAC-301; CV-301Phase 2 ClinicalTherion BiologicsAdenocarcinoma; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Cystadenocarcinoma; Intestinal Neoplasms; Melanoma; Neoplasm Metastasis; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours; Urinary Bladder Neoplasms
상세
NEO-201NEO-201Phase 2 ClinicalNational Cancer Institute, Precision Biologics IncCarcinoma, Non-Small-Cell Lung; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms; Uterine Neoplasms
상세
Anti-CEA CAR T cell therapy (Shanghai GeneChem)Phase 2 ClinicalShanghai Genechem Co LtdColorectal Neoplasms; Liver Neoplasms
상세
BMS-986490BMS-986490Phase 2 ClinicalBristol-Myers Squibb CompanySolid tumours
상세
LM-24C5LM-24C5Phase 2 ClinicalLaNova Medicines LtdNeoplasms; Solid tumours
상세
Precemtabart tocentecanM-9140; M9140Phase 2 ClinicalMerck KGaA, Darmstadt, GermanyCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms
상세
MFE-23-CD3z T cell therapy (Cancer Research Technology)Phase 1 ClinicalCancer Research TechnologyNeoplasms
상세
anti-CEA CAR T-cell therapy (Shanghai First Song Therapeutics)Phase 1 ClinicalShanghai Simcere Pharmaceutical Co LtdColorectal Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Small Intestine Cancers; Solid tumours; Stomach Neoplasms
상세
125-Iodine-labeled MFE-23Phase 1 ClinicalCancer Research UKNeoplasms
상세
anti-CEA CAR-T cell therapy (Sorrento/TNK therapeutics/Roger Williams Medical Center)Phase 1 ClinicalBeth Israel Deaconess Medical CenterAdenocarcinoma; Liver Neoplasms; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours
상세
CEACAM5-TOPO1 ADC (Bristol-Myers Squibb Company)Phase 1 ClinicalBristol-Myers Squibb CompanySolid tumours
상세
124I-M5APhase 1 ClinicalCity Of Hope National Medical Center, National Cancer InstituteColorectal Neoplasms
상세
IBI-3020IBI3020; IBI-3020Phase 1 ClinicalXinda Biomedical Technology (Hangzhou) Co LtdNeoplasm Metastasis; Solid tumours
상세
SGN-CEACAM5CPF-08046050; SGN-CEACAM5C; SAR445953; SAR-445953Phase 1 ClinicalSanofi, Seagen IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Gastroesophageal Junction Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Stomach Neoplasms
상세
EBC-129EBC129; EBC-129Phase 1 ClinicalExperimental Drug Development CentreSolid tumours
상세
GB-5012GB-5012ClinicalShanghai Genbase Biotechnology Co LtdColonic Neoplasms
상세

제품 리뷰

  • n***l2026-08-21
    0사람들이 좋아합니다
    This protein was purchased for target testing. The product was very easy to reconstitute and produced accurate results. The shipping speed of the product was more efficient than estimated which was greatly appreciated. We enjoy ordering high quality products from Acro.
  • 분자 정보
  • 제품 목록
  • 제품 리뷰
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호